RxDoctor Payments Data

Dennis Burachinsky, DO

Otolaryngology/Facial Plastic Surgery · Bridgewater, NJNPI 1427376698

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 94.9% of the total across 154 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 25 manufacturers reported payments, led by Sanofi at 24.7% of the total.

$2,996in general payments, 2019–2025

Across 154 payments — averaging $19.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi$739
  • Optinose US, Inc.$540
  • Regeneron Healthcare Solutions, Inc.$309
  • Takeda Pharmaceuticals U.S.A., Inc.$230
  • Aerin Medical Inc.$203
  • GSK$173
  • plus $803 from 19 others

What the payments were for

  • Food & beverage$2,84495%
  • Education$1525%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,996 in reported general payments places this provider in the 70th percentile of 36 otolaryngology/facial plastic surgery providers in New Jersey.

See all otolaryngology/facial plastic surgery providers in New Jersey

Medicare billing

Part B allowed, 2024
$207,333
Medicare patients
553
Services billed
2,420

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Azelastine Hcl114$2,720
Fluticasone Propionate119$1,796
Ipratropium Bromide47$1,060
Omeprazole81$1,003
Famotidine86$962
Montelukast Sodium59$663
Ofloxacin12$431
Fluocinolone Acetonide Oil11$332
Levocetirizine Dihydrochloride41$258
Mupirocin32$230
Methylprednisolone34$210
Pantoprazole Sodium11$163
Doxycycline Hyclate25$161
Azithromycin21$116
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav11$99

Paid to pharmacies, not to this prescriber.

Other otolaryngology/facial plastic surgery in Bridgewater

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →